{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:30:39Z","timestamp":1792179039660,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE1252522"],"award-info":[{"award-number":["DGE1252522"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE1252522"],"award-info":[{"award-number":["DGE1252522"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1DP2OD026005-01"],"award-info":[{"award-number":["1DP2OD026005-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biomed Eng"],"DOI":"10.1038\/s41551-019-0465-5","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T17:04:07Z","timestamp":1572887047000},"page":"84-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":283,"title":["Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability"],"prefix":"10.1038","volume":"4","author":[{"given":"Nicholas G.","family":"Lamson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Fein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0100-7824","authenticated-orcid":false,"given":"Kathryn A.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"465_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/jan.13818","volume":"75","author":"J McLenon","year":"2018","unstructured":"McLenon, J. & Rogers, M. A. M. The fear of needles: a systematic review and meta-analysis. J. Adv. Nurs. 75, 30\u201342 (2018).","journal-title":"J. Adv. Nurs."},{"key":"465_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/NMC.0b013e3181fc6093","volume":"36","author":"CJ Howe","year":"2011","unstructured":"Howe, C. J., Ratcliffe, S. J., Tuttle, A., Dougherty, S. & Lipman, T. H. Needle anxiety in children with type 1 diabetes and their mothers. MCN Am. J. Matern. Child Nurs. 36, 25\u201331 (2011).","journal-title":"MCN Am. J. Matern. Child Nurs."},{"key":"465_CR3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cden.2010.06.012","volume":"54","author":"CJ Sokolowski","year":"2010","unstructured":"Sokolowski, C. J., Giovannitti, J. A. & Boynes, S. G. Needle phobia: etiology, adverse consequences, and patient management. Dent. Clin. North Am. 54, 731\u2013734 (2010).","journal-title":"Dent. Clin. North Am."},{"key":"465_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2337\/dc09-1348","volume":"33","author":"M Peyrot","year":"2010","unstructured":"Peyrot, M., Rubin, R. R., Kruger, D. F. & Travis, L. B. Correlates of insulin injection omission. Diabetes Care 33, 240\u2013245 (2010).","journal-title":"Diabetes Care"},{"key":"465_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0168-8227(99)00099-6","volume":"46","author":"A Zambanini","year":"1999","unstructured":"Zambanini, A., Newson, R. B., Maisey, M. & Feher, M. D. Injection related anxiety in insulin-treated diabetes. Diabetes Res. Clin. Pract. 46, 239\u2013246 (1999).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"465_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.addr.2016.01.010","volume":"101","author":"E Moroz","year":"2015","unstructured":"Moroz, E., Matoori, S. & Leroux, J. C. Oral delivery of macromolecular drugs: where we are after almost 100 years of attempts. Adv. Drug Deliv. Rev. 101, 108\u2013121 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"465_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","volume":"11","author":"M Morishita","year":"2006","unstructured":"Morishita, M. & Peppas, N. A. Is the oral route possible for peptide and protein drug delivery?. Drug Discov. Today 11, 905\u2013910 (2006).","journal-title":"Drug Discov. Today"},{"key":"465_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-physiol-012110-142150","volume":"73","author":"L Shen","year":"2011","unstructured":"Shen, L., Weber, C. R., Raleigh, D. R., Yu, D. & Turner, J. R. Tight junction pore and leak pathways: a dynamic duo. Annu. Rev. Physiol. 73, 283\u2013309 (2011).","journal-title":"Annu. Rev. Physiol."},{"key":"465_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jconrel.2012.01.017","volume":"161","author":"RJ Mrsny","year":"2012","unstructured":"Mrsny, R. J. Oral drug delivery research in Europe. J. Control. Release 161, 247\u2013253 (2012).","journal-title":"J. Control. Release"},{"key":"465_CR10","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.4155\/tde.11.132","volume":"2","author":"EG Walsh","year":"2011","unstructured":"Walsh, E. G. et al. Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET\u00ae). Ther. Deliv. 2, 1595\u20131610 (2011).","journal-title":"Ther. Deliv."},{"key":"465_CR11","doi-asserted-by":"publisher","first-page":"7296","DOI":"10.1073\/pnas.1722338115","volume":"115","author":"A Banerjee","year":"2018","unstructured":"Banerjee, A. et al. Ionic liquids for oral insulin delivery. Proc. Natl Acad. Sci. USA 115, 7296\u20137301 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"465_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1007\/s11095-017-2149-8","volume":"34","author":"KC Fein","year":"2017","unstructured":"Fein, K. C., Lamson, N. G. & Whitehead, K. A. Structure-function analysis of phenylpiperazine derivatives as intestinal permeation enhancers. Pharm. Res. 34, 1320\u20131329 (2017).","journal-title":"Pharm. Res."},{"key":"465_CR13","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1007\/s11095-016-1975-4","volume":"33","author":"VA Bzik","year":"2016","unstructured":"Bzik, V. A. & Brayden, D. J. An assessment of the permeation enhancer, 1-phenyl-piperazine (PPZ), on paracellular flux across rat intestinal mucosae in Ussing chambers. Pharm. Res. 33, 2506\u20132516 (2016).","journal-title":"Pharm. Res."},{"key":"465_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1177\/1932296814529988","volume":"8","author":"E Zijlstra","year":"2014","unstructured":"Zijlstra, E., Heinemann, L. & Plum-M\u00f6rschel, L. Oral insulin reloaded: a structured approach. J. Diabetes Sci. Technol. 8, 458\u2013465 (2014).","journal-title":"J. Diabetes Sci. Technol."},{"key":"465_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1177\/1932296817691303","volume":"11","author":"E Arbit","year":"2017","unstructured":"Arbit, E. & Kidron, M. Oral insulin delivery in a physiologic context: review. J. Diabetes Sci. Technol. 11, 825\u2013832 (2017).","journal-title":"J. Diabetes Sci. Technol."},{"key":"465_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.addr.2016.02.004","volume":"106","author":"TAS Aguirre","year":"2016","unstructured":"Aguirre, T. A. S. et al. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials. Adv. Drug Deliv. Rev. 106, 223\u2013241 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"465_CR17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1021\/acs.molpharmaceut.5b00803","volume":"13","author":"NG Lamson","year":"2016","unstructured":"Lamson, N. G., Cusimano, G., Suri, K., Zhang, A. & Whitehead, K. A. The pH of piperazine derivative solutions predicts their utility as transepithelial permeation enhancers. Mol. Pharm. 13, 578\u2013585 (2016).","journal-title":"Mol. Pharm."},{"key":"465_CR18","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s11095-007-9488-9","volume":"25","author":"K Whitehead","year":"2008","unstructured":"Whitehead, K., Karr, N. & Mitragotri, S. Safe and effective permeation enhancers for oral drug delivery. Pharm. Res. 25, 1782\u20131788 (2008).","journal-title":"Pharm. Res."},{"key":"465_CR19","doi-asserted-by":"crossref","unstructured":"McCartney, F., Gleeson, J. P. & Brayden, D. J. Safety concerns over the use of intestinal permeation enhancers: a mini-review. Tissue Barriers 4, (2016).","DOI":"10.1080\/21688370.2016.1176822"},{"key":"465_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1021\/nl3037799","volume":"13","author":"KR Kam","year":"2013","unstructured":"Kam, K. R. et al. Nanostructure-mediated transport of biologics across epithelial tissue: enhancing permeability via nanotopography. Nano Lett. 13, 164\u2013171 (2013).","journal-title":"Nano Lett."},{"key":"465_CR21","doi-asserted-by":"publisher","first-page":"310ra168","DOI":"10.1126\/scitranslmed.aaa5937","volume":"7","author":"CM Schoellhammer","year":"2015","unstructured":"Schoellhammer, C. M. et al. Ultrasound-mediated gastrointestinal drug delivery. Sci. Transl. Med. 7, 310ra168 (2015).","journal-title":"Sci. Transl. Med."},{"key":"465_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.10.022","volume":"151","author":"W Fan","year":"2018","unstructured":"Fan, W. et al. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery. Biomaterials 151, 13\u201323 (2018).","journal-title":"Biomaterials"},{"key":"465_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1021\/mp400493b","volume":"11","author":"X Zhu","year":"2014","unstructured":"Zhu, X. et al. Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery. Mol. Pharm. 11, 317\u2013328 (2014).","journal-title":"Mol. Pharm."},{"key":"465_CR24","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1021\/acs.biomac.8b00215","volume":"19","author":"L Liu","year":"2018","unstructured":"Liu, L. et al. pH- and amylase-responsive carboxymethyl starch\/poly (2-isobutyl-acrylic acid) hybrid microgels as effective enteric carriers for oral insulin delivery. Biomacromolecules 19, 2123\u20132136 (2018).","journal-title":"Biomacromolecules"},{"key":"465_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jconrel.2016.05.015","volume":"233","author":"J Sheng","year":"2016","unstructured":"Sheng, J. et al. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates. J. Control. Release 233, 181\u2013190 (2016).","journal-title":"J. Control. Release"},{"key":"465_CR26","doi-asserted-by":"publisher","first-page":"25444","DOI":"10.1021\/acsami.6b08183","volume":"8","author":"W Shan","year":"2016","unstructured":"Shan, W. et al. Enhanced oral delivery of protein drugs using zwitterion-functionalized nanoparticles to overcome both the diffusion and absorption barriers. ACS Appl. Mater. Interf. 8, 25444\u201325453 (2016).","journal-title":"ACS Appl. Mater. Interf."},{"key":"465_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.biomaterials.2016.06.059","volume":"103","author":"JH Lee","year":"2016","unstructured":"Lee, J. H., Sahu, A., Choi, W. I., Lee, J. Y. & Tae, G. ZOT-derived peptide and chitosan functionalized nanocarrier for oral delivery of protein drug. Biomaterials 103, 160\u2013169 (2016).","journal-title":"Biomaterials"},{"key":"465_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jconrel.2017.09.003","volume":"264","author":"CY Wong","year":"2017","unstructured":"Wong, C. Y., Al-Salami, H. & Dass, C. R. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment. J. Control. Release 264, 247\u2013275 (2017).","journal-title":"J. Control. Release"},{"key":"465_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1208\/s12248-013-9456-8","volume":"15","author":"CA Larregieu","year":"2013","unstructured":"Larregieu, C. A. & Benet, L. Z. Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements. AAPS J. 15, 483\u2013497 (2013).","journal-title":"AAPS J."},{"key":"465_CR30","doi-asserted-by":"publisher","first-page":"G922","DOI":"10.1152\/ajpgi.2001.280.5.G922","volume":"280","author":"C Atuma","year":"2001","unstructured":"Atuma, C., Strugala, V., Allen, A. & Holm, L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G922\u2013G929 (2001).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"465_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ejpb.2015.01.005","volume":"96","author":"J Grie\u00dfinger","year":"2015","unstructured":"Grie\u00dfinger, J. et al. Methods to determine the interactions of micro- and nanoparticles with mucus. Eur. J. Pharm. Biopharm. 96, 464\u2013476 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"465_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","volume":"14","author":"SC Bischoff","year":"2014","unstructured":"Bischoff, S. C. et al. Intestinal permeability \u2013 a new target for disease prevention and therapy. BMC Gastroenterol. 14, 189 (2014).","journal-title":"BMC Gastroenterol."},{"key":"465_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jconrel.2015.05.270","volume":"210","author":"A Taverner","year":"2015","unstructured":"Taverner, A. et al. Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation. J. Control. Release 210, 189\u2013197 (2015).","journal-title":"J. Control. Release"},{"key":"465_CR34","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s10439-016-1558-x","volume":"44","author":"V Gupta","year":"2016","unstructured":"Gupta, V. et al. Delivery of exenatide and insulin using mucoadhesive intestinal devices. Ann. Biomed. Eng. 44, 1993\u20132007 (2016).","journal-title":"Ann. Biomed. Eng."},{"key":"465_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1172\/JCI27073","volume":"116","author":"DS Edgerton","year":"2006","unstructured":"Edgerton, D. S. et al. Insulin\u2019s direct effects on the liver dominate the control of hepatic glucose production. J. Clin. Invest. 116, 521\u2013527 (2006).","journal-title":"J. Clin. Invest."},{"key":"465_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0378-5173(92)90349-7","volume":"78","author":"I Morishita","year":"1992","unstructured":"Morishita, I., Morishita, M., Takayama, K., Machida, Y. & Nagai, T. Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. Int. J. Pharm. 78, 9\u201316 (1992).","journal-title":"Int. J. Pharm."},{"key":"465_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1211\/jpp.60.1.0008","volume":"60","author":"EL McConnell","year":"2008","unstructured":"McConnell, E. L., Basit, A. W. & Murdan, S. Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments. J. Pharm. Pharmacol. 60, 63\u201370 (2008).","journal-title":"J. Pharm. Pharmacol."},{"key":"465_CR38","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1021\/js980337n","volume":"88","author":"AM Lowman","year":"1999","unstructured":"Lowman, A. M., Morishita, M., Kajita, M., Nagai, T. & Peppas, N. A. Oral delivery of insulin using pH responsive complexation gels. J. Pharm. Sci. 88, 933\u2013937 (1999).","journal-title":"J. Pharm. Sci."},{"key":"465_CR39","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s12325-017-0499-6","volume":"34","author":"S Genovese","year":"2017","unstructured":"Genovese, S., Mannucci, E. & Ceriello, A. A review of the long-term efficacy, tolerability, and safety of exenatide once weekly for type 2 diabetes. Adv. Ther. 34, 1791\u20131814 (2017).","journal-title":"Adv. Ther."},{"key":"465_CR40","first-page":"5.47.1","volume":"70","author":"KK Wu","year":"2015","unstructured":"Wu, K. K. & Huan, Y. Streptozotocin-induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. 70, 5.47.1\u20135.47.20 (2015).","journal-title":"Curr. Protoc. Pharmacol."},{"key":"465_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1517\/17425255.4.4.395","volume":"4","author":"H Sun","year":"2008","unstructured":"Sun, H., Chow, E. C., Liu, S., Du, Y. & Pang, K. S. The Caco-2 cell monolayer: usefulness and limitations. Expert Opin. Drug Metab. Toxicol. 4, 395\u2013411 (2008).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"465_CR42","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.nano.2014.02.014","volume":"10","author":"MA Lopes","year":"2014","unstructured":"Lopes, M. A. et al. Intestinal absorption of insulin nanoparticles: contribution of M cells. Nanomed. Nanotechnol. Biol. Med. 10, 1139\u20131151 (2014).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"465_CR43","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1021\/nl504829f","volume":"15","author":"L Walsh","year":"2015","unstructured":"Walsh, L. et al. Nanotopography facilitates in vivo transdermal delivery of high molecular weight therapeutics through an integrin-dependent mechanism. Nano Lett. 15, 2434\u20132441 (2015).","journal-title":"Nano Lett."},{"key":"465_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2006.03.031","volume":"247","author":"MZ Gilcrease","year":"2007","unstructured":"Gilcrease, M. Z. Integrin signaling in epithelial cells. Cancer Lett. 247, 1\u201325 (2007).","journal-title":"Cancer Lett."},{"key":"465_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-pathol-011110-130224","volume":"6","author":"WA Muller","year":"2011","unstructured":"Muller, W. A. Mechanisms of leukocyte transendothelial migration. Annu. Rev. Pathol. 6, 323\u2013344 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"465_CR46","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2741\/A429","volume":"4","author":"J-F Beaulieu","year":"1999","unstructured":"Beaulieu, J.-F. Integrins and human intestinal cell functions. Front. Biosci. 4, 310\u2013321 (1999).","journal-title":"Front. Biosci."},{"key":"465_CR47","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.xphs.2015.10.030","volume":"105","author":"M \u00d6lander","year":"2016","unstructured":"\u00d6lander, M., Wi\u015bniewski, J. R., Matsson, P., Lundquist, P. & Artursson, P. The proteome of filter-grown Caco-2 cells with a focus on proteins involved in drug disposition. J. Pharm. Sci. 105, 817\u2013827 (2016).","journal-title":"J. Pharm. Sci."},{"key":"465_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.addr.2006.01.003","volume":"58","author":"NN Salama","year":"2006","unstructured":"Salama, N. N., Eddington, N. D. & Fasano, A. Tight junction modulation and its relationship to drug delivery. Adv. Drug Deliv. Rev. 58, 15\u201328 (2006).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"465_CR49","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3109\/17435390.2014.944599","volume":"9","author":"Agata P. Walczak","year":"2014","unstructured":"Walczak, A. P. et al. Translocation of differently sized and charged polystyrene nanoparticles in in vitro intestinal cell models of increasing complexity. Nanotoxicology 9, 453-461 (2014).","journal-title":"Nanotoxicology"},{"key":"465_CR50","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1016\/j.actbio.2013.04.009","volume":"9","author":"SH Yu","year":"2013","unstructured":"Yu, S. H. et al. Nanoparticle-induced tight-junction opening for the transport of an anti-angiogenic sulfated polysaccharide across Caco-2 cell monolayers. Acta Biomater. 9, 7449\u20137459 (2013).","journal-title":"Acta Biomater."},{"key":"465_CR51","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s00204-017-1993-y","volume":"91","author":"S Murugadoss","year":"2017","unstructured":"Murugadoss, S. et al. Toxicology of silica nanoparticles: an update. Arch. Toxicol. 91, 2967\u20133010 (2017).","journal-title":"Arch. Toxicol."},{"key":"465_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jconrel.2004.04.013","volume":"98","author":"K Whitehead","year":"2004","unstructured":"Whitehead, K., Shen, Z. & Mitragotri, S. Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. J. Control. Release 98, 37\u201345 (2004).","journal-title":"J. Control. Release"},{"key":"465_CR53","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/btm2.10015","volume":"1","author":"A Banerjee","year":"2016","unstructured":"Banerjee, A., Lee, J. & Mitragotri, S. Intestinal mucoadhesive devices for oral delivery of insulin. Bioeng. Transl. Med. 1, 338\u2013346 (2016).","journal-title":"Bioeng. Transl. Med."},{"key":"465_CR54","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nprot.2010.43","volume":"5","author":"L Young","year":"2010","unstructured":"Young, L., Sung, J., Stacey, G. & Masters, J. R. Detection of Mycoplasma in cell cultures. Nat. Protoc. 5, 929\u2013934 (2010).","journal-title":"Nat. Protoc."},{"key":"465_CR55","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1023\/A:1012112820371","volume":"14","author":"S Chong","year":"1997","unstructured":"Chong, S., Dando, S. A. & Morrison, R. A. Evaluation of Biocoat\u00ae Intestinal Epithelium Differentiation Environment (3-day cultured Caco-2 cells) as an absorption screening model with improved screening productivity. Pharm. Res. 14, 1835\u20131837 (1997).","journal-title":"Pharm. Res."},{"key":"465_CR56","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jps.10050","volume":"91","author":"S Yamashita","year":"2002","unstructured":"Yamashita, S. et al. New and better protocols for a short-term Caco-2 cell culture system. J. Pharm. Sci. 91, 669\u2013679 (2002).","journal-title":"J. Pharm. Sci."},{"key":"465_CR57","doi-asserted-by":"publisher","first-page":"e57136","DOI":"10.1371\/journal.pone.0057136","volume":"8","author":"V Gupta","year":"2013","unstructured":"Gupta, V., Doshi, N. & Mitragotri, S. Permeation of insulin, calcitonin and exenatide across Caco-2 monolayers: measurement using a rapid, 3-day system. PLoS ONE 8, e57136 (2013).","journal-title":"PLoS ONE"},{"key":"465_CR58","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","volume":"9","author":"Q Xu","year":"2015","unstructured":"Xu, Q. et al. Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo. ACS Nano 9, 9217\u20139227 (2015).","journal-title":"ACS Nano"},{"key":"465_CR59","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ejpb.2014.12.024","volume":"97","author":"I Pereira De Sousa","year":"2015","unstructured":"Pereira De Sousa, I. et al. Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles. Eur. J. Pharm. Biopharm. 97, 273\u2013279 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"465_CR60","doi-asserted-by":"publisher","first-page":"e0133154","DOI":"10.1371\/journal.pone.0133154","volume":"10","author":"RL Ball","year":"2015","unstructured":"Ball, R. L., Knapp, C. M. & Whitehead, K. A. Lipidoid nanoparticles for siRNA delivery to the intestinal epithelium: in vitro investigations in a Caco-2 model. PLoS ONE 10, e0133154 (2015).","journal-title":"PLoS ONE"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-019-0465-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-019-0465-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-019-0465-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T03:37:42Z","timestamp":1671248262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-019-0465-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["465"],"URL":"https:\/\/doi.org\/10.1038\/s41551-019-0465-5","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"26 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.A.W. and N.G.L. are registered as inventors on Patent Cooperation Treaty (PCT) application PCT\/US2018\/042035, which covers aspects of the technology presented here.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}